Form D Explorer

Form D — Zucara Therapeutics Inc.

0002059295-25-000002 · filed 2025-03-06

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $4,999,978
Total sold: $4,999,978
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Zucara Therapeutics Inc.
CIK: 2059295
Entity: Corporation
Jurisdiction: CANADA (FEDERAL LEVEL)
Year incorporated: —
Address: 1300-661 UNIVERSITY AVENUE
TORONTO, A6 M5G 0B7
Phone: 4168593978

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Michael Midmer · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Claude A Piche · Director

Toronto, A6 Find on LinkedIn ↗
Michael Martin · Director

Toronto, A6 Find on LinkedIn ↗
Chris Garabedian · Director

Toronto, A6 Find on LinkedIn ↗
Fred Callori · Director

Toronto, A6 Find on LinkedIn ↗
Richard Liggins · Executive Officer

Toronto, A6 Find on LinkedIn ↗
Janet Grove · Executive Officer

Toronto, A6 Find on LinkedIn ↗

View original on SEC EDGAR.